{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:03:09Z","timestamp":1790218989030,"version":"4.1.0"},"reference-count":47,"publisher":"China Science Publishing & Media Ltd.","issue":"10","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2025,10,1]]},"DOI":"10.3724\/abbs.2025019","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T05:11:50Z","timestamp":1739769110000},"page":"1696-1708","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["Divergent roles of PKM2 in regulating PD-L1 and PD-L2 expression and their implications in human and mouse cancer models"],"prefix":"10.3724","volume":"57","author":[{"given":"Shuo","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangwu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","volume":"42","author":"Galassi C","year":"2024","unstructured":"Galassi C, Chan TA, Vitale I, Galluzzi L. The hallmarks of cancer immune evasion. Canc Cell, 2024, 42: 1825-1863.","journal-title":"Canc Cell"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"113343","DOI":"10.1016\/j.celrep.2023.113343","volume":"42","author":"Liu Y","year":"2023","unstructured":"Liu Y, Peng Y, Du W, Yu C, Peng Z, Qin L, Ma Y. PD-L1-mediated immune evasion in triple-negative breast cancer is linked to the loss of ZNF652. Cell Rep, 2023, 42:","journal-title":"Cell Rep"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12964-023-01063-x","volume":"21","author":"Watterson A","year":"2023","unstructured":"Watterson A, Coelho MA. Cancer immune evasion through KRAS and PD-L1 and potential therapeutic interventions. Cell Commun Signal, 2023, 21:","journal-title":"Cell Commun Signal"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"e002699","DOI":"10.1136\/jitc-2021-002699","volume":"9","author":"Xu Y","year":"2021","unstructured":"Xu Y, Gao Z, Hu R, Wang Y, Wang Y, Su Z, Zhang X. PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy. J Immunother Canc, 2021, 9:","journal-title":"J Immunother Canc"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"108000","DOI":"10.1016\/j.celrep.2020.108000","volume":"32","author":"Xu Y","year":"2020","unstructured":"Xu Y, Wu Y, Zhang S, Ma P, Jin X, Wang Z, Yao M. A Tumor-Specific super-enhancer drives immune evasion by guiding synchronous expression of PD-L1 and PD-L2. Cell Rep, 2020, 32:","journal-title":"Cell Rep"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"115984","DOI":"10.1016\/j.bcp.2023.115984","volume":"220","author":"Liu D","year":"2024","unstructured":"Liu D, Wen C, Chen L, Ye M, Liu H, Sun X, Liang L. The emerging roles of PD-L1 subcellular localization in tumor immune evasion. Biochem Pharmacol, 2024, 220:","journal-title":"Biochem Pharmacol"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"1359532","DOI":"10.3389\/fimmu.2024.1359532","volume":"15","author":"Yang Y","year":"2024","unstructured":"Yang Y, Yan X, Bai X, Yang J, Song J. Programmed cell death-ligand 2: new insights in cancer. Front Immunol, 2024, 15:","journal-title":"Front Immunol"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"e35571","DOI":"10.1097\/MD.0000000000035571","volume":"102","author":"Zhang S","year":"2023","unstructured":"Zhang S, Liao Z, Li S, Luo Y. Non-metabolic enzyme function of PKM2 in hepatocellular carcinoma: A review. Medicine, 2023, 102:","journal-title":"Medicine"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"1450325","DOI":"10.3389\/fonc.2024.1450325","volume":"14","author":"Jemal M","year":"2024","unstructured":"Jemal M, Getinet M, Amare GA, Tegegne BA, Baylie T, Mengistu EF, Osman EE. Non-metabolic enzyme function of pyruvate kinase M2 in breast cancer. Front Oncol, 2024, 14:","journal-title":"Front Oncol"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/cbin.12103","volume":"48","author":"He S","year":"2024","unstructured":"He S, Liang Y, Tan Y, Liu Q, Liu T, Lu X, Zheng S. Positioning determines function: Wandering PKM2 performs different roles in tumor cells. Cell Biol Int, 2024, 48: 20-30.","journal-title":"Cell Biol Int"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"216964","DOI":"10.1016\/j.canlet.2024.216964","volume":"593","author":"Yu Y","year":"2024","unstructured":"Yu Y, Liang Y, Xie F, Zhang Z, Zhang P, Zhao X, Zhang Z. Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation. Canc Lett, 2024, 593:","journal-title":"Canc Lett"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.3389\/fimmu.2017.01300","volume":"8","author":"Palsson-McDermott EM","year":"2017","unstructured":"Palsson-McDermott EM, Dyck L, Zas\u0142ona Z, Menon D, McGettrick AF, Mills KHG, O\u2019Neill LA. Pyruvate kinase M2 is required for the expression of the immune checkpoint PD-L1 in immune cells and tumors. Front Immunol, 2017, 8:","journal-title":"Front Immunol"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41418-024-01317-2","volume":"31","author":"Wang S","year":"2024","unstructured":"Wang S, Su D, Chen H, Lai JC, Tang C, Li Y, Wang Y. PD-L2 drives resistance to EGFR-TKIs: Dynamic changes of the tumor immune environment and targeted therapy. Cell Death Differ, 2024, 31: 1140-1156.","journal-title":"Cell Death Differ"},{"key":"CITATION14","doi-asserted-by":"crossref","unstructured":"Wang Z, Jensen MA, Zenklusen JC. A Practical Guide to The Cancer Genome Atlas (TCGA).  Methods Mol Biol  2016, 1418: 111\u2013141.","DOI":"10.1007\/978-1-4939-3578-9_6"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5114\/wo.2014.47136","volume":"1A","author":"Tomczak K","year":"2015","unstructured":"Tomczak K, Czerwi\u0144ska P, Wiznerowicz M. Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn), 2015, 1A: 68-77.","journal-title":"Contemp Oncol (Pozn)"},{"key":"CITATION16","doi-asserted-by":"crossref","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling Tumor Infiltrating Immune Cells with CIBERSORT.  Methods Mol Biol  2018, 1711: 243-259.","DOI":"10.1007\/978-1-4939-7493-1_12"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"119781","DOI":"10.1016\/j.bbamcr.2024.119781","volume":"1871","author":"Liang Y","year":"2024","unstructured":"Liang Y, He S, Liu Q, Liu T, Tan Y, Peng T, Huang C. Vimentin, inversely correlating with infiltration of CD8\u2005+\u2005T lymphocytes, promotes nuclear translocation of PD-L1 in esophageal squamous cell carcinoma. Biochim Biophys Acta, 2024, 1871:","journal-title":"Biochim Biophys Acta"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12950-023-00341-2","volume":"20","author":"Li Y","year":"2023","unstructured":"Li Y, Tan R, Li R, Tian R, Liu Z, Wang X, Chen E. PKM2\/STAT1-mediated PD-L1 upregulation on neutrophils during sepsis promotes neutrophil organ accumulation by serving an anti-apoptotic role. J Inflamm, 2023, 20:","journal-title":"J Inflamm"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"577108","DOI":"10.3389\/fphar.2020.577108","volume":"11","author":"Wang X","year":"2020","unstructured":"Wang X, Liang C, Yao X, Yang RH, Zhang ZS, Liu FY, Li WQ. PKM2-Induced the phosphorylation of histone H3 contributes to EGF-Mediated PD-L1 transcription in HCC. Front Pharmacol, 2020, 11:","journal-title":"Front Pharmacol"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"e6793","DOI":"10.1002\/cam4.6793","volume":"13","author":"Shimasaki Y","year":"2024","unstructured":"Shimasaki Y, Miyoshi H, Kawamoto K, Yoshida N, Mishina T, Nakashima K, Imamoto T. Clinicopathological comparison between PTCL\u2010TBX21 and PTCL\u2010GATA3 in Japanese patients. Canc Med, 2024, 13:","journal-title":"Canc Med"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/eji.201040979","volume":"41","author":"Wolfle SJ","year":"2011","unstructured":"Wolfle SJ, Strebovsky J, Bartz H, S\u00e4hr A, Arnold C, Kaiser C, Dalpke AH. PD\u2010L1 expression on tolerogenic APCs is controlled by STAT\u20103. Eur J Immunol, 2011, 41: 413-424.","journal-title":"Eur J Immunol"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"216861","DOI":"10.1016\/j.canlet.2024.216861","volume":"590","author":"Wang L","year":"2024","unstructured":"Wang L, Liu X, Han Y, Tsai H, Dan Z, Yang P, Xu Z. TRAF6 enhances PD-L1 expression through YAP1-TFCP2 signaling in melanoma. Canc Lett, 2024, 590:","journal-title":"Canc Lett"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.4049\/jimmunol.2100917","volume":"209","author":"Wijdeven RH","year":"2022","unstructured":"Wijdeven RH, Cabukusta B, Behr FM, Qiu X, Amiri D, Borras DM, Arens R. CRISPR activation screening identifies VGLL3\u2013TEAD1\u2013RUNX1\/3 as a transcriptional complex for PD-L1 expression. J Immunol, 2022, 209: 907-915.","journal-title":"J Immunol"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"e2120540119","DOI":"10.1073\/pnas.2120540119","volume":"119","author":"Oreskovic E","year":"2022","unstructured":"Oreskovic E, Wheeler EC, Mengwasser KE, Fujimura E, Martin TD, Tothova Z, Elledge SJ. Genetic analysis of cancer drivers reveals cohesin and CTCF as suppressors of PD-L1. Proc Natl Acad Sci USA, 2022, 119:","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41588-021-00778-2","volume":"53","author":"Papalexi E","year":"2021","unstructured":"Papalexi E, Mimitou EP, Butler AW, Foster S, Bracken B, Mauck Iii WM, Wessels HH. Characterizing the molecular regulation of inhibitory immune checkpoints with multimodal single-cell screens. Nat Genet, 2021, 53: 322-331.","journal-title":"Nat Genet"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"e0178765","DOI":"10.1371\/journal.pone.0178765","volume":"12","author":"Hirose T","year":"2017","unstructured":"Hirose T, Tanaka Y, Tanaka A, Sakai H, Sasaki Y, Shinohara N, Ohdan H. PD-L1\/PD-L2-expressing B-1 cells inhibit alloreactive T cells in mice. PLoS ONE, 2017, 12:","journal-title":"PLoS ONE"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00262-018-2263-4","volume":"68","author":"Umezu D","year":"2019","unstructured":"Umezu D, Okada N, Sakoda Y, Adachi K, Ojima T, Yamaue H, Eto M. Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment. Canc Immunol Immunother, 2019, 68: 201-211.","journal-title":"Canc Immunol Immunother"},{"key":"CITATION28","doi-asserted-by":"crossref","unstructured":"Kalinski P, Talmadge JE. Tumor Immuno-Environment in Cancer Progression and Therapy.  Adv Exp Med Biol  2017, 1036: 1\u201318.","DOI":"10.1007\/978-3-319-67577-0_1"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"CIN.S32696","DOI":"10.4137\/CIN.S32696","volume":"14","author":"Bennani-Baiti N","year":"2015","unstructured":"Bennani-Baiti N, Bennani-Baiti IM. Cancer Bioinformatic Methods to Infer Meaningful Data from Small-Size Cohorts. Canc Inform, 2015, 14:","journal-title":"Canc Inform"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4291\/wjgp.v13.i1.1","volume":"13","author":"El-Nakeep S","year":"2022","unstructured":"El-Nakeep S. Molecular and genetic markers in hepatocellular carcinoma: In silico analysis to clinical validation (current limitations and future promises). WJGP, 2022, 13: 1-14.","journal-title":"WJGP"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s13105-021-00813-0","volume":"77","author":"Zheng S","year":"2021","unstructured":"Zheng S, Liu Q, Liu T, Lu X. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered. J Physiol Biochem, 2021, 77: 355-363.","journal-title":"J Physiol Biochem"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"1230465","DOI":"10.3389\/fimmu.2023.1230465","volume":"14","author":"Wang YW","year":"2023","unstructured":"Wang YW, Zuo JC, Chen C, Li XH. Post-translational modifications and immune responses in liver cancer. Front Immunol, 2023, 14:","journal-title":"Front Immunol"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.gpb.2019.11.010","volume":"18","author":"Ning W","year":"2020","unstructured":"Ning W, Xu H, Jiang P, Cheng H, Deng W, Guo Y, Xue Y. HybridSucc: a hybrid-learning architecture for general and species-specific succinylation site prediction. Genomics Proteomics BioInf, 2020, 18: 194-207.","journal-title":"Genomics Proteomics BioInf"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"e1004053","DOI":"10.1371\/journal.pcbi.1004053","volume":"11","author":"Nussinov R","year":"2015","unstructured":"Nussinov R. Advancements and challenges in computational biology. PLoS Comput Biol, 2015, 11:","journal-title":"PLoS Comput Biol"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13059-021-02292-4","volume":"22","author":"Jafari M","year":"2021","unstructured":"Jafari M, Guan Y, Wedge DC, Ansari-Pour N. Re-evaluating experimental validation in the Big Data Era: A conceptual argument. Genome Biol, 2021, 22:","journal-title":"Genome Biol"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"e67995","DOI":"10.7554\/eLife.67995","volume":"10","author":"Errington TM","year":"2021","unstructured":"Errington TM, Denis A, Perfito N, Iorns E, Nosek BA. Challenges for assessing replicability in preclinical cancer biology. eLife, 2021, 10:","journal-title":"eLife"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/656340","volume":"2012","author":"Rozali EN","year":"2012","unstructured":"Rozali EN, Hato SV, Robinson BW, Lake RA, Lesterhuis WJ. Programmed death ligand 2 in cancer-induced immune suppression. Clin Dev Immunol, 2012, 2012: 1-8.","journal-title":"Clin Dev Immunol"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"e1390641","DOI":"10.1080\/2162402X.2017.1390641","volume":"7","author":"Ahmad SM","year":"2018","unstructured":"Ahmad SM, Martinenaite E, Holmstr\u00f6m M, J\u00f8rgensen MA, Met \u00d6, Nastasi C, Klausen U. The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy. OncoImmunology, 2018, 7:","journal-title":"OncoImmunology"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s40425-019-0703-0","volume":"7","author":"Zhang Y","year":"2019","unstructured":"Zhang Y, Xu J, Hua J, Liu J, Liang C, Meng Q, Wei M. A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma. j immunoTher Canc, 2019, 7:","journal-title":"j immunoTher Canc"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/jcp-2023-209017","volume":"76","author":"Qiang Z","year":"2023","unstructured":"Qiang Z, Jubber I, Lloyd K, Cumberbatch M, Griffin J. Gene of the month: GATA3. J Clin Pathol, 2023, 76: 793-797.","journal-title":"J Clin Pathol"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1007\/s12033-023-00778-z","volume":"66","author":"Zhang C","year":"2024","unstructured":"Zhang C, Huang Z. KAT2A promotes the succinylation of PKM2 to inhibit its activity and accelerate glycolysis of gastric cancer. Mol Biotechnol, 2024, 66: 1446-1457.","journal-title":"Mol Biotechnol"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"e0211515","DOI":"10.1371\/journal.pone.0211515","volume":"14","author":"Verma K","year":"2019","unstructured":"Verma K, Patel A, Wu Q. Pyruvate Kinase M2 serves as blockade for nucleosome repositioning and abrogates Chd7 remodeling activity. PLoS ONE, 2019, 14:","journal-title":"PLoS ONE"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"11435","DOI":"10.3390\/ijms150711435","volume":"15","author":"Chen L","year":"2014","unstructured":"Chen L, Shi Y, Liu S, Cao Y, Wang X, Tao Y. PKM2: the thread linking energy metabolism reprogramming with epigenetics in cancer. Int J Mol Sci, 2014, 15: 11435-11445.","journal-title":"Int J Mol Sci"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.molimm.2022.05.004","volume":"149","author":"Chang Q","year":"2022","unstructured":"Chang Q, Yin D, Li H, Du X, Wang Z, Liu Y, Zhang J. HDAC6-specific inhibitor alleviates hashimoto\u2032s thyroiditis through inhibition of Th17 cell differentiation. Mol Immunol, 2022, 149: 39-47.","journal-title":"Mol Immunol"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41419-021-03579-x","volume":"12","author":"Gu J","year":"2021","unstructured":"Gu J, Li X, Zhao L, Yang Y, Xue C, Gao Y, Li J. The role of PKM2 nuclear translocation in the constant activation of the NF-\u03baB signaling pathway in cancer-associated fibroblasts. Cell Death Dis, 2021, 12:","journal-title":"Cell Death Dis"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12943-015-0490-2","volume":"15","author":"Azoitei N","year":"2016","unstructured":"Azoitei N, Becher A, Steinestel K, Rouhi A, Diepold K, Genze F, Simmet T. PKM2 promotes tumor angiogenesis by regulating HIF-1\u03b1 through NF-\u03baB activation. Mol Canc, 2016, 15:","journal-title":"Mol Canc"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"110401","DOI":"10.1016\/j.intimp.2023.110401","volume":"121","author":"Yuan L","year":"2023","unstructured":"Yuan L, Wang Y, Chen Y, Chen X, Li S, Liu X. Shikonin inhibits immune checkpoint PD-L1 expression on macrophage in sepsis by modulating PKM2. Int Immunopharmacol, 2023, 121:","journal-title":"Int Immunopharmacol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/4DBBB291E7D349F59681B87C8C9C848B","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025019","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/4DBBB291E7D349F59681B87C8C9C848B","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:49:31Z","timestamp":1761882571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,2,20]]},"published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2025019","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,20]]}}}